Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05897_nanopub.RAE0zCRHxfBTLz7s7_MtJK9NqcVx0w3JH0DjcaCj69YHI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05897 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05897 label "rhIGFBP-3 [drugbank:DB05897]" assertion.
- drugbank:DB05897 seeAlso DB05897 assertion.
- drugbank:DB05897 identifier "drugbank:DB05897" assertion.
- drugbank:DB05897 description "rhIGFBP-3 (recombinant human insulin-like growth factor binding protein-3) is Insmed’s proprietary anti-cancer compound that has demonstrated significant decreases in cancerous growth in several models of human. It is developed by Insmed and is currently under phase I of the clinical trail." assertion.
- drugbank:DB05897 title "rhIGFBP-3" assertion.
- drugbank:DB05897 bio2rdf_vocabulary:identifier "DB05897" assertion.
- drugbank:DB05897 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05897 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05897" assertion.
- drugbank:DB05897 bio2rdf_vocabulary:x-identifiers.org DB05897 assertion.
- drugbank:DB05897 drugbank_vocabulary:drugbank-id "DB05897" assertion.
- drugbank:DB05897 drugbank_vocabulary:x-cas cas: assertion.